DISCLOR F FNNCL RLATN · 2020-06-15 · 1 DISCLOR F FNNCL RLATN In compliance with the standards set by the Accreditation Council for Continuing Medical Education (ACCME), it is the

1

DISCLOSURE OF FINANCIAL RELATIONSHIPS

In compliance with the standards set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the American Association for Cancer Research (AACR) that the information presented at CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR has provided information that planning committee members, speakers, and abstract presenters have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity.

Relationships are abbreviated as follows: E, Employee of listed company, G, Grant/research support recipient, A, Advisor or review panel member, C, Consultant, S, Stock Shareholder, SB, Speakers’ Bureau, H, Honoraria, O, Other.

Last Name First Name Company Relationships Type Role

Abernethy Amy U.S. Food and Drug Administration No Relationships Speaker

Achilefu Samuel Washington University School of Medicine, McDonnell Genome Institute

Kingdom Capital Inc. C,O Program Committee

Adamson Peter Children’s Hospital of Philadelphia No Relationships Program Committee

Aguirre-Ghiso Julio Icahn School of Medecine at Mount Sinai HiberCell, LLC A,C,G, H,S,O

Program Committee

Ahdesmäki Miika AstraZeneca AstraZeneca E Speaker

Ainscow Edward Carrick Therapeutics Carrick Therapeutics E Speaker

Albini Adriana Fondazione MultiMedica Onlus, ITALY No Relationships Program Committee

Alimonti Andrea Institute of Oncology Research IOR Oncosence; AstraZeneca; Astellas Pharma Inc A,G,S Speaker

Alizadeh Ash Stanford University Roche, Genentech, Jannssen, Pharmacyclics, Gilead, Celgene, Chugai, Pfizer

C Speaker

Al-Lazikani Bissan Institute of Cancer Research Astex Pharmaceutical, GSK, Astellas Pharma, Definines AG

A,C,H,O Speaker

Alter Orly University of Utah Huntsman Cancer Institute Eigengene, Inc. O Speaker

Altorki Nasser Weill Cornell Medical College View point; TMRW; AstraZeneca; Angiocrine Bioscience

G,S Speaker

Amit Ido Weizmann Institute of Science No Relationships Program Committee

Amos Christopher Baylor College of Medicine No Relationships Speaker

Anafi Ron University of Pennsylvania No Relationships Speaker

Anderl Jan Merck KGaA Merck; EMD Serono E,O Speaker

Anderson Kenneth Dana-Farber Cancer Institute Sanofi-Aventis; Precision Biosciences; Millennium-Takeda; Janssen; Gilead; Celgene; Bristol-Myers Squibb

C Speaker

Last Name First Name Company Relationships Type Role

2

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Angelo R. Michael Stanford University Ionpath A,C Program Committee, Speaker

Anurag Meenakshi Baylor College of Medicine No Relationships Speaker

Araojo RADM Richardae

U.S. Food and Drug Administration No Relationships Speaker

Arpaia Nicholas Columbia University Irving Medical Center Merck & Co., Inc.; GenCirq, Inc. C,S Speaker

Arruabarrena-Aristorena

Amaia Memorial Sloan Kettering Cancer Center No Relationships Speaker

Arthur Ronald American Association for Cancer Research No Relationships Program Committee

Azad Nilofer Johns Hopkins Sidney Kimmel Comp. Cancer Center No Relationships Program Committee

Bailey Howard University of Wisconsin Carbone Comp. Cancer Center

Forte; Capio BioSciences, Inc A Speaker

Baran Amy American Association for Cancer Research No Relationships Program Committee

Bargonetti Jill City University of New York at Hunter College and the Graduate Center

No Relationships Speaker

Barksdale Elizabeth American Association for Cancer Research No Relationships Program Committee

Barnholtz-Sloan Jill Case Western Reserve University School of Med. No Relationships Speaker

Barrette Anne Marie Icahn School of Medicine at Mount Sinai No Relationships Speaker

Bassik Michael Stanford University Medical Center Boehringer Ingleheim G Speaker

Baylin Stephen Johns Hopkins University School of Medicine MDxHealth, Mirati Therapeutics, Aminex Therapeutics

C,O Program Committee, Speaker

Bedard Philippe Princess Margaret Cancer Centre BMS, Genentech, Pfizer, Jazz Pharmaceuticals, Seattle, Genetics, Roche/Genentech, Merck, BMS, Sanofi, AstraZeneca, Lilly, Novartis, Zymeworks

G Program Committee

Bedrosian Isabelle UT MD Anderson Cancer Center No Relationships Speaker

Ben-David Uri Tel Aviv University No Relationships Speaker

Bendell Johanna Sarah Cannon Research Institute No Relationships Speaker

Berger Shelly University of Pennsylvania School of Medicine No Relationships Program Committee

Bergers Gabriele VIB-KU Leuven Center for Cancer Biology Oncurious O Speaker

Last Name First Name Company Relationships Type Role

3

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Bernards René Netherlands Cancer Institute Oncosence S Speaker

Bertolini Giulia Fondazione IRCCS Istituto Nazionale Tumori No Relationships Speaker

Berx Geert Ghent University/VIB No Relationships Speaker

Bhardwaj Nina Mt. Sinai Medical Center Neon Therapeutics; Tempest Therapeutics; Checkpoint Sciences; Curevac; PICI; Novacure; Celldex; Genentech; Oncovir; Avidea; Primevax; Novartis; Array BioPharma; Roche; Rome, BI; Roswell Park; Janssen; Regeneron

A,G Program Committee

Bhatt Vrushank Rutgers Cancer Institute of New Jersey No Relationships Speaker

Biegel Jaclyn Children’s Hospital Los Angeles No Relationships Speaker

Bigot Ludovic Institut Gustave Roussy No Relationships Speaker

Biru Yelak International Myeloma Foundation No Relationships Speaker

Bivona Trever UCSF Revolution Medicines, Novartis, AstraZeneca, Array Biopharma, Jazz

A,C,G Speaker

Black Morgan London Health Sciences Center No Relationships Speaker

Blank Christian Netherlands Cancer Institute BMS, AZ, Pfizer, Lilly, GenMab, Pierre Fabre, Nanostring, Uniti Cars, MSD, Roche, Novartis, GSK

A,G,S Program Committee

Blank Christian Netherlands Cancer Institute/Antoni van Leeuwenhoek (NKI-AvL)

NanoString; BMS; BMS, MSD, Roche, Novartis, GSK, AZ, Pfizer, Lilly, GenMab, Pierre Fabre; BMS, Novartis, NanoString; Forty Seven; GenMab; GSK; AZ; MSD; Uniti Cars; Neon Therapeutics; Neon Therapeutics, Forty Seven, Unity Cars; Novartis; Pfizer; Pierre-Fab

A,G,S Speaker

Borghaei Hossein Fox Chase Cancer Center Takeda; Incyte; BMS; Lilly; Genentech; Celgene; Merck; EMD Serono; BI; AZ; Novartis; Genmab; Regeneron; BioNTech; Cantargia AB; Amgen; AbbVie; Axiom; PharmaMar; Huya Bio, GLG; Millennium; Pfizer; Sonnetbio; Rgenix; Daiichi Sankyo

A,C,G, H,O

Speaker

Boshoff Chris Pfizer, Inc. Medical Oncology Pfizer E Speaker

Bossard Carine Samumed, LLC Samumed, LLC E Speaker

Bozhanova Galabina The Institute of Cancer Research No Relationships Speaker

Last Name First Name Company Relationships Type Role

4

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Brands Michael Bayer AG Bayer E Speaker

Breunig Joshua Cedars-Sinai Medical Center No Relationships Speaker

Brody Joshua Icahn School of Medicine at Mount Sinai Seattle Genetics; Merck; Kite; Genentech; Celldex; Celgene; BMS; Acerta

G Speaker

Brody Julia Silent Spring Institute No Relationships Speaker

Brummond Kay University of Pittsburgh No Relationships Speaker

Buhrlage Sara Dana-Farber Cancer Institute No Relationships Speaker

Burgenske Danielle Mayo Clinic No Relationships Speaker

Burslem George Perelman School of Medicine, University of Pennsylvania

No Relationships Speaker

Burzyn Dalia Codiak BioSciences Codiak BioSciences E Speaker

Buschhaus Johanna University of Michigan No Relationships Speaker

Byun Jinyoung Baylor College of Medicine No Relationships Speaker

Calin George UT MD Anderson Cancer Center No Relationships Speaker

Calizo Lyngine American Association for Cancer Research No Relationships Program Committee

Campbell Kerry Fox Chase Cancer Center NantKwest; Janssen Pharma; Immune Oncology Biosciences

G,O Speaker

Campbell Nathaniel Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program

No Relationships Speaker

Campisi Judith Buck Institute for Research on Aging Unity Biotechnology G,S Program Committee

Cao Yin Washington University No Relationships Speaker

Cardoso Fatima Champalimaud Cancer Center Amgen, Astellas/Medivation, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GlaxoSmithKline (GSK), Macrogenics, Merck-Sharp, Merus BV, Mylan, Mundipharma, Novartis, Pfizer, Pierre-Fabre, Roche, Sanofi, Seattle Genetics, Samsung Bioepis, Teva, Prime Oncology, Teva, BI, BMS, Fresenius, Ipsen,Incyte, Nektar Therapeutics, Nerviano, Medigene, Pfizer, Sonus, Tesaro, Tigris, Wilez, Wyeth

C,G,H Program Committee

Last Name First Name Company Relationships Type Role

5

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Carr Steven Broad Inst. of MIT and Harvard No Relationships Speaker

Carroll Martin Univ. of Pennsylvania Janssen Pharmaceuticals; Incyte Pharmaceuticals

C,G Speaker

Chae Young Northwestern University Immuneoncia; AstraZeneca; Biodesix; Boehringher Ingelheim; Bristol-Myers Squibb; Counsyl; Foundation Medicine; Abbvie; Guardant Health; Tempus; Lexent Bio; Lilly Oncology; Merck; Neogenomics; Novartis; Roche/Genentech; Takeda; Freenome Honoraria/Advisory

G,A,SB Speaker

Chakraborty Abhishek The Cleveland Clinic Lerner Research Institute No Relationships Speaker

Chander Ashok Combinatorial Strategies, LLC and Cellanyx Combinatorial Strategies, LLC; Cellanyx E Speaker

Chang Howard Stanford University Spring Discovery; Boundless Bio; Arsenal Biosciences; Accent Therapeutics; 10x Genomics

A,C,S Speaker

Chen Alice National Cancer Inst. No Relationships Speaker

Chen Mei-Kuang University of Texas MD Anderson Cancer Center No Relationships Speaker

Chen Qing The Wistar Institute No Relationships Speaker

Chheda Milan Washington University UpToDate; NeoimmuneTech G,O Speaker

Chinegwudoh Francis Barts and the London NHS Trust No Relationships Speaker

Chowdhury Sreyan Columbia University GenCirq, Inc C Speaker

Christensen Brock Dartmouth Geisel School of Medicine No Relationships Speaker

Christofk Heather UCLA David Geffen School of Medicine Agios Pharamaceuticals, Pelage Pharmaceuticals

A,S Program Committee

Cocco Emiliano Memorial Sloan Kettering Cancer Center No Relationships Speaker

Coghill Anna H. Lee Moffitt Cancer Center and Research Institute No Relationships Speaker

Colditz Graham Washington University School of Medicine GRAIL, Inc. A Speaker

Contessa Joseph Yale University Springbank Pharma G Program Committee

Last Name First Name Company Relationships Type Role

6

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Corcoran Ryan Massachusetts General Hospital Amgen, Array Biopharma, Astex Pharmaceuticals, Avidity Biosciences, BMS, Chugai, Fog Pharma, Fount Therapeutics, Genentech, LOXO, Merrimack, N-of-one, Novartis, Revolution Medicine, Roche, Roivant, Shionogi, Shire, Spectrum Pharmaceuticals, Symphogen, Taiho, Warp Drive Bio, Avidity Biosciences, Fount Therapeutics, nRichDx, Asana, AZ, Sanofi, C4, Elicio

A,C,G,S, SB,O

Program Committee, Speaker

Corey Eva University of Washington Janssen; Kronos Bio; Bayer Pharmaceuticals; Gilead; Sanofi

G Speaker

Coussens Lisa OHSU Knight Cancer Institute Zymeworks, Inc.; Verseau Therapeutics, Inc.; Syndax Pharmaceuticals, Inc.; Pharmacyclics, Inc.; Innate Pharma; CytomX Therapeutics, Inc.; Cell Signaling Technologies; Carisma Therapeutics, Inc.

A,C,G Speaker

Cravatt Benjamin The Scripps Research Institute Vividion Therapeutics; Pfizer; Eisai; Boundless Bio

A Speaker

Crawford Howard University of Michigan No Relationships Speaker

Crosby David Cancer Research UK No Relationships Program Committee, Speaker

Croucher Peter Garvan Institute of Medical Research Amgen G,SB Speaker

Cruz-Correa Marcia University of Puerto Rico Comp. Cancer Center BeiGene A Program Committee, Speaker

Cugnetti Ana Paula BioAtla BioAtla E Speaker

Cukierman Edna Fox Chase Cancer Center Trammel G Program Committee, Speaker

Curtis Christina Stanford University No Relationships Program Committee

Dang Chi Van The Wistar Institute Rafael, Dracen, Polaris A,H Program Committee

Daver Naval UT MD Anderson Cancer Center Pfizer; Novartis; Immunogen; Genentech; Forty Seven; Daiichi-Sankyo; BMS; Astellas; Agios; AbbVie

A,G,H Speaker

Davis Melissa Weill Cornell Medical College No Relationships Program Committee

Last Name First Name Company Relationships Type Role

7

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Davis-Marcisak Emily Johns Hopkins School of Medicine No Relationships Speaker

Dawson Mark Peter MacCallum Cancer Center Storm Therapeutics; GlaxoSmithKline; CTX CRC; Cambridge Epigenetix

A,G,H Speaker

De Bono Johann Royal Marsden NHS Foundation Trust Astra Zeneca, Astellas Pharma, Bayer, Boehringer Ingelheim, Celgene; Genentech/Roche, Daiichi Sankyo, CellCentric, Genmab, GSK, Janssen Oncology, Merck Serono, Merck Sharp & Dohme; Menarini Silicon Biosystems; Orion Pharma GmbH; Pfizer, Qiagen, Sanofi Aventis, Sierra Oncology, Taiho; Eisai, BioXCel Therapeutics, Pfizer

A,G Program Committee

De Carvalho Daniel Princess Margaret Cancer Centre Pfizer; Nektar therapeutics G Speaker

De Marzo Angelo Johns Hopkins University School of Medicine Myriad Genetics; Janssen R&D; Cepheid Inc C,G Speaker

De Velasco Marco Kindai University Faculty of Medicine AstraZeneca G Speaker

de Vries E. G. Elisabeth University Medical Center Groningen, The Netherlands NSABP, Sanofi, Daiichi Sankyo, Amgen, Genentech, Roche, AZ, Synthon, Nordic Nanovector, G1 Therapeutics, Bayer, Chugai Pharma, CytomX Therapeutics, Radius Health

A,C,G Program Committee

Debnath Jayanta UCSF Vescor Therapeutics, LLC A Speaker

DeGregori James University of Denver No Relationships Speaker

Dehghannasiri Roozbeh Stanford University No Relationships Speaker

Delgoffe Greg University of Pittsburgh Western Oncolytics; TTMS, Inc.; TCR2 Therapeutics; Pieris Pharmaceuticals; Pfizer; Bluebird Bio

A,C,G,S Speaker

Della Peruta Marco Autolus Therapeutics Autolus Therapeutics E Speaker

Demetri George Dana-Farber Cancer Institute No Relationships Speaker

Denardo David Washington Univ. School of Medicine No Relationships Program Committee, Speaker

DeNicola Gina H. Lee Moffitt Cancer Center & Research Institute No Relationships Speaker

Dhar Shilpa UT MD Anderson Cancer Center No Relationships Speaker

Diaz Luis Memorial Sloan Kettering Cancer Center Thrive Detect; Personal Genome Diagnostics; Neophore; Merck; 4 Paws

A,C,G,S Speaker

Last Name First Name Company Relationships Type Role

8

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Diaz-Meco Maria Sanford Burnham Prebys Medical Discovery Institute No Relationships Speaker

Dick John University of Toronto Trillium Therapeutics Inc; Celgene A,G,S Speaker

Diehn Maximilian Stanford University School of Medicine Roche, AstraZeneca, BioNTech Varian, Sanofi, Genyzme, CiberMed

C,G,S Speaker

Ding Ke Jinan University No Relationships Speaker

Dipersio John Washington University School of Medicine WUGEN; Rivervest Venture Partners; NeoImmune Tech; Magenta Therapeutics; Karyopharm Therapeutics; Incyte; Cellworks Group, Inc.; Celgene; Arch Oncology; Amphivena Therapeutics

A,C,G, H,O

Speaker

Dive Caroline Cancer Research UK Manchester Institute Ad Hoc, AZ, Merck, Ilumina, Angle, Amgen, Menarini, Astex, Bioven, Carrick, Taiho, Clearbridge, GSK, Bayer, BI, Roche, BMS, Novartis, Celgene

C,G Program Committee

Dixon Jesse Salk Institute No Relationships Speaker

Domcheck Susan Abramson Cancer Center of University of Pennsylvania

AZ, Clovis, BMS H Program Committee

Downing James St. Jude Children’s Research Hospital No Relationships Speaker

Dragovich Peter Genentech, Inc. Genentech, Inc. E Speaker

Drebin Jeffrey Memorial Sloan Kettering Cancer Center American Regent Pharma , Ionis Pharma, Alnylam Pharma

E,S Program Committee

Drilon Alexander Memorial Sloan Kettering Cancer Center Ignyta/Genentech/Roche; Loxo/Bayer/Lilly; Takeda/Ariad/Millenium; TP Therapeutics; AstraZeneca; Pfizer; Blueprint Medicines; Helsinn; Beigene; BergenBio; Hengrui Therapeutics; Exelixis; Tyra Biosciences; Verastem; AbbVie; 14ner/Elevation Oncology; Remedica Ltd.; ArcherDX; Monopteros; GlaxoSmithKlein, Teva, Taiho, PharmaMar

O,H,G Speaker

Dudley Andrew University of Virginia No Relationships Speaker

Dvorak Harold Beth Israel Deaconess Medical Center Angiex S,O Speaker

Echeverria Gloria Baylor College of Medicine No Relationships Speaker

Edmondson Scott AstraZeneca AstraZeneca E,S Speaker

Last Name First Name Company Relationships Type Role

9

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Egeblad Mikala Cold Spring Harbor Laboratory MPM Gilead; CytomX; Blackstone Life Sciences Fund; Agios Pharmaceutical

C,H,S,O Speaker

Eggermont Alexander Institute Gustave Roussy Biocad, Biovent, BMS, CatalYm, FRAME, GI Innolife, GSK, IO Biotech, ISA Pharmaceuticals, MSD, Merck, Novartis, Roche, Sanofi, Sellas, RiverDiagnostics, SkylineDx, Theranovir

A,H,S,SB Program Committee

Elemento Olivier Weill Cornell Medical College of Cornell Univ. Volastra Therapeutics; Owkin; One Three Biotech; Genetic Intelligence; Freenome; Eli Lily, Janssen, Sanofi; Acuamark

O Speaker

Engels Eric National Cancer Institute No Relationships Speaker

Engstrom Lars Mirati Therapeutics Mirati Therapeutics E Speaker

Erez Ayelet Weizmann Institute of Science No Relationships Speaker

Estey Elihu Fred Hutchinson Cancer Research No Relationships Speaker

Evrard Yvonne Leidos Biomedical Research, Inc. No Relationships Speaker

Fashoyin-Aje Lola U.S. Food and Drug Administration No Relationships Speaker

Fatema Kaniz Idaho State University No Relationships Speaker

Fawell Stephen AstraZeneca AstraZeneca E,S Speaker

Fearon Douglas Cold Spring Harbor Laboratory No Relationships Speaker

Fedewa Stacey American Cancer Society No Relationships Speaker

Fedorov Andriy Brigham and Women’s Hospital, Harvard Medical School

No Relationships Speaker

Ferrara Katherine Stanford University No Relationships Speaker

Fertig Elana Johns Hopkins Sidney Kimmel Comp. Cancer Center Champions Oncology C Speaker

Filbin Mariella Dana Farber Cancer Institute No Relationships Speaker

Fischbach Claudia Cornell University No Relationships Speaker

Fisher Stewart C4 Therapeutics C4 Therapeutics E Speaker

Last Name First Name Company Relationships Type Role

10

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Flaherty Keith Massachusetts General Hospital Cancer Center Clovis Oncology, Strata Oncology, Vivid Biosciences, Checkmate Pharmaceuticals, X4 Pharmaceuticals, PIC Therapeutics, Sanofi, Amgen, Asana, Adaptimmune, Fount, Aeglea, Shattuck Labs, Tolero, Apricity, Oncoceutics, Fog Pharma, Neon, Tvardi, xCures, Monopteros, Vibliome, Novartis, Genentech, BMS, Merck, Takeda, Verastem, Boston Biomedical, Pierre Fabre, Debiopharm

A,C,S Program Committee

Flavahan William Massachusetts General Hospital Charles River Laboratories O Speaker

Fong Christopher Memorial Sloan Kettering Cancer Center No Relationships Speaker

Fong Lawrence UCSF Roche/Genentech; Merck; Janssen; Dendreon; BMS; Bavarian Nordic; AbbVie

G Speaker

Ford Heide University of Colorado Denver School of Medicine No Relationships Speaker

Formenti Silvia Weill Cornell Medical College BMS; Varian; Janssen; Regneron; Eisai; Merck ; Celldex; Elekta; AstraZeneca; ViewRay; GSK; Bayer

G,H Program Committee, Speaker

Foti Margaret American Association for Cancer Research No Relationships Program Committee

Fourie Zirkelbach Jeanne U.S. Food and Drug Administration No Relationships Speaker

Freed-Pastor William MIT Koch Institute for Integrated Cancer Res. No Relationships Speaker

Friedl Peter Radboud Univ. Nijmegen Medical Ctr. LaVision Biotech; Grintech; Altum G,O Speaker

Fukumura Dai MGH/Harvard Medical School Merck; Eisai H Speaker

Galanis Evanthia Mayo Clinic College of Medicine AstraZeneca; Tracon; Genentech; BMS; Karyopharm

G,O Speaker

Galbraith Susan AstraZeneca AstraZeneca Pharmaceuticals LP, Horizon Discovery

A,E,S Program Committee

Galloway Denise Fred Hutchinson Cancer Research Center Merck A,G Speaker

Gao Jennifer U.S. Food and Drug Administration Worldcare, Inc C Speaker

Gao Jianjiong Memorial Sloan Kettering Cancer Center No Relationships Speaker

Garnett Mathew Wellcome Trust Sanger Institute AstraZeneca, Sanofi G,H Speaker

Gauttier Vanessa OSE Immunotherapeutics OSE Immunotherapeutics E Speaker

Last Name First Name Company Relationships Type Role

11

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Geisler Stefanie Washington University Saint Louis No Relationships Speaker

George Daniel Duke University Medical Center No Relationships Speaker

Getz Kayla University of Michigan No Relationships Speaker

Ghobrial Irene Dana-Farber Cancer Institute GSK; Genentech; Sanofi; Janssen; Takeda; Celgene; Karyopharm; AbbVie; GNS; Cellectar; Adaptive MedScape

C,H Program Committee, Speaker

Ghosh Soma U.S. Food and Drug Administration No Relationships Speaker

Giannakis Marios Dana-Farber Cancer Institute Merck; Bristol-Myers Squibb G Speaker

Gibbs Lee USC Keck School of Medicine No Relationships Speaker

Gibbs Summer Oregon Health & Science University Inherent Targeting, LLC A Speaker

Gieffers Christian Apogenix AG Apogenix AG E Speaker

Gilkes Daniele Johns Hopkins University School of Medicine No Relationships Speaker

Gill Saar Univ. of Pennsylvania School of Medicine Tmunity Therapeutics; Intellia; Carisma Therapeutics

A,G,S Speaker

Gillison Maura The University of Texas MD Anderson Cancer Center Merck, Roche, Roche, EMB Sereno, Bayer Health CarePharm, BMS, AstraZeneca,

C,G,H, SB,O

Program Committee

Gimple Ryan University of California, San Diego No Relationships Speaker

Giordano Jessica University of Torino No Relationships Speaker

Goecks Jeremy OHSU Knight Cancer Institute GalaxyWorks A Speaker

Goel Sanjay Montefiore Medical Center No Relationships Speaker

Goldmacher Gregory Merck Merck E Speaker

Goodell Margaret Baylor College of Medicine No Relationships Program Committee

Goodman Karyn Icahn School of Medicine at Mount Sinai RenovoRx A Speaker

Goodrich David Roswell Park Cancer Institute No Relationships Speaker

Gormley Nicole U.S. Food and Drug Administration No Relationships Speaker

Gou Xuxu Baylor College of Medicine No Relationships Speaker

Goverse Gera OcellO B.V. OcellO B.V. E Speaker

Govindan Ramaswamy Washington University School of Medicine GENEPLUS; Achilles C Speaker

Last Name First Name Company Relationships Type Role

12

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Gozgit Joseph Ribon Therapeutics, Inc Ribon Therapeutics, Inc E Speaker

Gradl Stefan Bayer AG Bayer AG E Speaker

Grandori Carla SEngine Precision Medicine SEngine Precision Medicine E Speaker

Greenberg Philip Fred Hutchinson Cancer Research Center & University of Washington

Juno Therapeutics, Fix Bio, Elpiscience, Nextech, Celsius

A,C,G,S Program Committee

Griffith Obi Washington University School of Medicine No Relationships Program Committee, Speaker

Grivennikov Sergei Fox Chase Cancer Center No Relationships Speaker

Grupp Stephan Children’s Hospital of Philadelphia Novartis, Kite, Servier, Novartis, Roche, GSK, Cure Genetics, Humanigen, CBMG, Jazz, Adaptimmune, TCR2, Eureka, Cellectis, Juno, Vertex, Patent

A,C,G,O Program Committee

Guerriero Jennifer Dana-Farber Cancer Institute Verseau Therapeutics; GlaxoSmithKline; Eli LIlly; Codagenix; Array BioPharma

C,G Speaker

Guise Theresa Indiana University School of Medicine No Relationships Program Committee

Guyton Kathryn International Agency for Research on Cancer (IARC) No Relationships Speaker

Guzman Monica Weill Cornell Medical College TemedOn; SeqRX; Cellectis; Amgen; AI Therapeutics

A,G,H Speaker

Haber Michelle Children’s Cancer Institute Australia No Relationships Speaker

Habowski Amber University of California, Irvine No Relationships Speaker

Hahn William Dana-Farber Cancer Institute Tyra Biosciences; Tyra; Thermo Fisher; Solvasta Ventures; Solvasta; Paraxel; MPM; KSQ Therapeutics; iTeos; Frontier Medicines

C,S,O Speaker

Halabi Susan Duke University No Relationships Program Committee

Hambardzumyan Dolores Icahn School of Medicine at Mount Sinai Merck C Speaker

Hamel Lauren Karmanos Cancer Institute, Wayne State University No Relationships Speaker

Hampel Heather The Ohio State University Comprehensive Cancer Center

Promega; Invitae Genetics; Genome Medical; 23andMe

A,C,S Speaker

Hartmaier Ryan AstraZeneca AstraZeneca E Speaker

Last Name First Name Company Relationships Type Role

13

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Harvey R. Donald Emory University School of Medicine AbbVie, Amgen, Arqule, AstraZeneca, Boston Biomedical, Calithera, Celgene, Corvus, Eli Lilly, Five Prime Therapeutics, Genmab, Halozyme, Ignyta, Incyte, Meryx, Nektar, Pfizer, Regeneron, Rgenix, Sanofi, Syndax, Takeda, Tesaro, Vertex, Xencor, Takeda, Bristol-Myers Squibb, GlaxoSmithKline

C,G Speaker

Haubein Lisa American Association for Cancer Research No Relationships Program Committee

Heath James Institute for Systems Biology PACT, Isoplexis, Indi Molecular, Sofie Biosciences, Merck

A,C,G Speaker

Heller Daniel Memorial Sloan Kettering Cancer Center Nirova Biosense, Inc.; LipidSense, Inc.; Goldilocks Therapeutics, Inc.; Concarlo Holdings, LLC

A,S Program Committee, Speaker

Hellmann Matthew Memorial Sloan Kettering Cancer Center Merck, Bristol-Myers Squibb, AstraZeneca, Genentech/Roche, Nektar, Syndax, Mirati, Shattuck Labs, Blueprint Medicines, Immunai, PGDx, Shattuck Labs, Immunai

C,G,H, S,O

Program Committee

Herbst Roy Yale University School of Medicine AbbVie, ARMO Biosciences, AZ, Biodesix, Bolt Biotherapeutics, BMS, Lilly, EMD Serono, Genentech/Roche, Genmab, Halozyme, Heat Biologics, IMAB Biopharma, Immunocore, Loxo, Merck, Midas Health Analytics, Mirati, Nektar, NextCure, Novartis, Pfizer, Sanofi, Seattle Genetics, Shire PLC, Spectrum Pharmaceuticals, Symphogen, Takeda, Tesaro, Tocagen, Neon Therapeutics, Infinity Pharmaceuticals, Junshi Pharmaceuticals

A,C,G Speaker

Herold Marco The Walter and Eliza Hall Institute of Medical Research No Relationships Speaker

Herranz Daniel Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey; NIH/NCI; New Jersey Commission on Cancer Research; Gabrielle’s Angel Foundation for Cancer Research; American Cancer Society (ACS); Alex’s Lemonade Stand Foundation

E,G Speaker

Hershman Dawn Herbert Irving Comprehensive Cancer Center No Relationships Program Committee

Last Name First Name Company Relationships Type Role

14

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Hidalgo Manuel Weill Cornell Medicine Celgene; Pfizer; Novartis; MSD; EMD; Ipsem; Shire; SOBI; Champions Oncology; Agenus; Erytech; Pharmacyte; Bioline; BioOncotech; Oncomatrix; VCN; Bayer; BMS; Nelum; Eng T Cells

A,C,SB,O Program Committee, Speaker

Hilsenbeck Susan Baylor College of Medicine, Dan L. Duncan Cancer Center

No Relationships Speaker

Hirsch Jonathan Syapse Syapse E Speaker

Hirz Taghreed MGH/Harvard Medical School No Relationships Speaker

Hoppin Polly University of Massachusetts, Lowell No Relationships Speaker

Hosseinchi Peyman University of Chicago No Relationships Speaker

Hsiao Jennifer Harvard/MGH No Relationships Speaker

Huarte Maite University of Navarra No Relationships Speaker

Huguet Nathalie Oregon Health & Science University (OSHU) No Relationships Speaker

Hyman David Memorial Sloan Kettering Cancer Center Chugai Pharma, CytomX, BI, AZ, Pfizer, Bayer, Genentech/Roche, Loxo, Puma, Fount,

A,C,G, S,O

Program Committee

Issaq Sameer National Cancer Institute No Relationships Speaker

Jabado Nada McGill University No Relationships Program Committee, Speaker

Jacks Tyler Koch Institute for Integrative Cancer Research at MIT Amgen. ; Thermo Fisher Scientific. ; Dragonfly Therapeutics. ; T2 Biosystems. ; Skyhawk Therapeautics. ; SQZ Biotech. ; Calico

A,E Speaker

James Ashley American Association for Cancer Research No Relationships Program Committee

Jeon Junhyeok Korea Advance Institute of Science and Technology (KAIST)

No Relationships Speaker

Jiang Changying The University of Texas MD Anderson Cancer Center No Relationships Speaker

Jiang Qingfei UCSD No Relationships Speaker

Jiang Wen UT Southwestern Medical Center Spot BioSystems G Speaker

Jin Chengcheng University of Pennsylvania No Relationships Speaker

Johnstone Ricky Peter MacCallum Cancer Center, Australia MecRx, Roche, BMS A,C,G,S Program Committee

Last Name First Name Company Relationships Type Role

15

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Jones Lyn Dana-Farber Cancer Institute Deerfield O Speaker

Jones Phil Wellcome Sanger Institute No Relationships Speaker

Kagawa-Singer Marjorie University of California No Relationships Speaker

Kakimi Kazuhiro University of Tokyo Hospital TAKARA BIO Inc.; MSD; Medinet Ltd. G,O Speaker

Kamm Roger Massachusetts Institute of Technology Gore; Elstar; Biogen; Amgen; AIM Biotech A,G,S Speaker

Kandimalla Raju Baylor Scott & White Research Institute No Relationships Speaker

Kang Yibin Princeton University Firebrand Therapeutics, Kayothera, Amgen, Glycomimetics, Cytocares

A,G,H,S Program Committee

Karchin Rachel Johns Hopkins University No Relationships Speaker

Karin Michael UC San Diego Johnson & Johnson Innovation, JLABS, Merck & Co., Genentech

G Speaker

Karthaus Wouter MSKCC Prostate Cancer Foundation; Organoid technology Co-Inventor

G,O Speaker

Kashima Kenji Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. E Speaker

Kassiotis George The Francis Crick Institute No Relationships Speaker

Kastan Michael Duke Cancer Center XRad Therapeutics S Program Committee

Kaufman Howard Immuneering Corporation Immuneering Corporation E Speaker

Kaur Harpreet Johns Hopkins University School of Medicine No Relationships Speaker

Kaur Judith Mayo Clinic Florida No Relationships Speaker

Keegan Patricia U.S. Food and Drug Administration No Relationships Speaker

Kemp Christopher Fred Hutchinson Cancer Research Center SEngine Precision Medicine A,S Speaker

Kerbel Robert Sunnybrook Research Institute OncoHost; Novelty Nobility, Inc.; NedBiosystems; CSTS Healthcare, Inc.

A,C Speaker

Khalil Ahmad Case Western Reserve Univ. School of Med. No Relationships Speaker

Khurana Ekta Weill Cornell Medical College No Relationships Speaker

Kleinstern Geffen Mayo Clinic No Relationships Speaker

Kluetz Paul Food and Drug Administration No Relationships Speaker

Knopp Michael Ohio State University No Relationships Program Committee

Last Name First Name Company Relationships Type Role

16

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Kolonin Mikhail The University of Texas Health Science Center at Houston

No Relationships Speaker

Koltun Elena Revolution Medicines Revolution Medicines E Speaker

Korkola James Oregon Health & Science University Convergent Genomics O Speaker

Koyfman Shlomo The Cleveland Clinic Varian medical systems; Uptodate; Merck; BristolmyersSquib; Bristol Myers Squib

G,H,O Speaker

Kozlova Edgar Icahn School of Medicine No Relationships Speaker

Kreeger Pamela University of Wisconsin Novartis G Speaker

Kregel Steven University of Michigan No Relationships Speaker

Kulasinghe Arutha School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology

No Relationships Speaker

Kumar Dhiraj Johns Hopkins Medicine No Relationships Speaker

Kuo Calvin Stanford University Surrozen, Inc. A Speaker

Kurebayashi Yutaka National Cancer Institute, National Institutes of Health No Relationships Speaker

Lacey James City of Hope No Relationships Speaker

Lam Wai Ling Macrina

German Cancer Research Center No Relationships Speaker

Landgren Ola Memorial Sloan Kettering Cancer Center Takeda; Janssen; BMS/Celgene; Binding Site; Amgen; Adaptive Biotech

A,G,H,O Speaker

Langer Corey University of Pennsylvania Merck, AbbVie, Bristol Myers Squibb, Pfizer, Lilly, AstraZeneca, Novartis, Roche/Genentech, Bayer/Onyx, Abbott, Morphotek, Biodesix, Clarient, Caris Dx, Vertex, Synta, Celgene, Boehringer-Ingelheim, Hospira, Helsinn, Clovis, Ariad (Takeda), Takai; Regeneron, Gilead, OSI (Astellas), GSK, Nektar, Advantagene, Inovio, StemCentrx, Guardant Health, Amgen, Synta, Agennix, SWOG, Peregrine, Incyte, PIK; PER; NOCR; Imedex, CCO; RTP, MLG, TRM, Web-MD

A,G,O Program Committee

Lathan Christopher Dana-Farber Cancer Institute No Relationships Program Committee

Lathia Justin The Cleveland Clinic Lerner Research Inst. No Relationships Speaker

Last Name First Name Company Relationships Type Role

17

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Le Xiuning Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center

EMD Serono; Eli Lilly; Boehringer Ingelheim; AstraZeneca

G,A,C Speaker

Leboeuf Nicole Brigham and Women’s Hospital Seattle Genetics; Cor2Ed; Bayer C,H Speaker

Lee Irene Dana-Farber Cancer Institute No Relationships Speaker

Lee J. Jack UT MD Anderson Cancer Center No Relationships Program Committee

Lemery Steven U.S. Food and Drug Administration No Relationships Speaker

Leonard M. Kathryn American Association for Cancer Research No Relationships Program Committee

Li Albert Stanford University School of Medicine No Relationships Speaker

Li Jun UT MD Anderson Cancer Center No Relationships Speaker

Li Pui Kai The Ohio State University, College of Pharmacy No Relationships Speaker

Li Sha Sanford Burnham Prebys Medical Discovery Institute No Relationships Speaker

Li Sheng The Jackson Laboratory No Relationships Speaker

Li Shijie “Chris” ChemoCentryx ChemoCentryx E Speaker

Liang Han UT MD Anderson Cancer Center Precision Scientific Ltd; Precision Scientific A,S Speaker

Ligorio Matteo University of Texas Southwestern Medical Center No Relationships Speaker

Lissanu Deribe Yonathan UT MD Anderson Cancer Center no company O Speaker

Liu Edison The Jackson Laboratory No Relationships Program Committee

Liu Jie Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis

No Relationships Speaker

Liu Ke U.S. Food and Drug Administration No Relationships Speaker

Liu Minmin Van Andel Research Institute No Relationships Speaker

Llor Xavier Yale University School of Medicine Exact Sciences A Speaker

Lopes Gilberto University of Miami No Relationships Speaker

Lopes-Ramos Camila Harvard T.H. Chan School of Public Health No Relationships Speaker

Lopez Juanita The Royal Marsden Hospital (Sutton, Surrey) Roche-Genentech. ; Basilea. ; Genmab G,A Speaker

Lu Sai San Moon Umeå University No Relationships Speaker

Last Name First Name Company Relationships Type Role

18

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Luca Bogdan Stanford University No Relationships Speaker

Lund Amanda Oregon Health and Science University No Relationships Program Committee

Lynch Lydia Trinity College Dublin Novo Nordisk G Speaker

Lyssiotis Costas University of Michigan No Relationships Speaker

Mack Jennifer Dana-Farber Cancer Institute No Relationships Speaker

Maddocks Oliver University of Glasgow Faeth Therapeutics Inc. A,S Speaker

Madhavan Subha Georgetown University Medical Center No Relationships Program Committee

Malinou Justin University of Maryland Greenebaum Comprehensive Cancer Center

No Relationships Speaker

Malkin David The Hospital for Sick Children Bayer Canada C Speaker

Mallick Parag Stanford University No Relationships Speaker

Manguso Robert Massachusetts General Hospital/Broad Institute Calico Life Sciences LLC G Speaker

Mano Hiroyuki National Cancer Center Research Institute, Tokyo, Japan

No Relationships Program Committee

Manor Uri Salk Institute Cancer Ctr. No Relationships Speaker

Mansfield James Magnetic Insight Magnetic Insight, Andor Technology E Speaker

Marabelle Aurelien Institute Gustave Roussy No Relationships Speaker

MARCHETTI DARIO UNM Health Sciences Center No Relationships Speaker

Marcus Daniel Washington University School of Medicine Sora Imaging Solutions; Radiologics, Inc O Speaker

Mardis Elaine Nationwide Children’s Hospital Qiagen NV; Pact Pharma LLC; Moderna Inc.; Interpreta LLC

A,S Program Committee, Speaker

Marson Alexander UCSF Arsenal Biosciences O Speaker

Martin Sarah American Association for Cancer Research No Relationships Program Committee

Martinek Jan Jackson Laboratory No Relationships Speaker

Martinez Elena University of California, San Diego No Relationships Program Committee

Marx Matthew Mirati Therapeutics Reglagene; Mirati Therapeutics A,E,S Speaker

Matei Daniela Northwestern University - Chicago, IL Radius; Merck G,H Speaker

Matyskiela Mary Celgene Corporation Celgene Corp. E Speaker

Last Name First Name Company Relationships Type Role

19

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Mazor Tali Dana-Farber Cancer Institute No Relationships Speaker

McAllister Florencia UT MD Anderson Cancer Center No Relationships Speaker

McHugh Colleen University of California, San Diego No Relationships Speaker

Mechta-Grigoriou Fatima Institut Curie Roche; Innate Pharma; BMS G,O Speaker

Melendez Brenda UT MD Anderson Cancer Center No Relationships Speaker

Melief Cornelis Leiden University Medical Center and ISA Pharmaceuticals

ISA Pharmaceuticals; Immatics A,E,S Speaker

Mellman Ira Genentech, Inc. Genentech E Program Committee

Merad Miriam Mount Sinai School of Medicine No Relationships Speaker

Mesa Ruben Mays Cancer Center at UT Health San Antonio Incyte; BMS; CTI; Novartis; AbbVie; Genentech; Sierra Oncology

G,H Speaker

Mesirov Jill UCSD No Relationships Program Committee, Speaker

Metcalfe Ciara Genentech, Inc. Genentech, Inc. E Speaker

Mischel Paul Ludwig Institute for Cancer Research Boundless Bio, Inc. S,O Speaker

Modlin Irvin Yale University School of Medicine Wren Laboratories C Speaker

Mole David University of Oxford No Relationships Speaker

Mooney David Harvard University No Relationships Speaker

Moore Malcolm Princess Margaret Hospital Gilead C Program Committee

Morgan Gareth NYU Langone Health Takeda; Sanofi; Roche; Karyopharm; GSK; Celgene

C,H Speaker

Morita Ken Dana-Farber Cancer Institute No Relationships Speaker

Mu Ping UT Southwestern Medical Center No Relationships Speaker

Mullooly Maeve Royal College of Surgeons in Ireland No Relationships Speaker

Nelson Shakira American Association for Cancer Research No Relationships Program Committee

Nephew Kenneth Indiana University School of Medicine Pfizer Pharmaceutical Company; Astex Pharmaceuticals Inc.

G Speaker

Newman Lisa Weill Cornell Medicine No Relationships Speaker

Nolan Garry Stanford University School of Medicine Ionpath; Akoya Biosciences A,S Speaker

Last Name First Name Company Relationships Type Role

20

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Nooka Ajay Emory University Winship Cancer Institute Janssen Pharmaceuticals; Takeda; Karyopharm; Spectrum; Oncopeptides; GSK

H,A,O Speaker

Nwokeji Esmond McKesson Life Sciences McKesson Life Sciences E Speaker

Obeng Esther St. Jude Children’s Research Hospital No Relationships Speaker

Odunsi Kunle Roswell Park Cancer Institute No Relationships Program Committee

Ohashi Pamela Princess Margaret Cancer Centre No Relationships Program Committee

Oike Naoki University of Colorado Anschutz Medical Campus No Relationships Speaker

Olive Kenneth NY Presbyterian Hospital Herbert Irving Comp. Cancer Center

No Relationships Speaker

Oliver Trudy University of Utah Huntsman Cancer Institute No Relationships Speaker

Olopade Olufunmilayo University of Chicago Medical Center CancerIQ Inc, Tempus, Roche A,G Program Committee

Othus Megan Fred Hutchinson Cancer Research Center Merck; Glycomimetics; Daiichi Sankyo; Celgene C,O Speaker

Pacold Michael NYU Langone Medical Center Thermo Fisher Scientific; Raze Therapeutics C,O Speaker

Pagel Mark UT MD Anderson Cancer Center No Relationships Speaker

Palmer Adam University of North Carolina at Chapel Hill No Relationships Speaker

Pardee Timothy Wake Forest University Rafael Pharmaceuticals; Pharmacyclics; Amgen C,SB Speaker

Parikh Aparna Massachusetts General Hospital Tesaro; Puretech; Novartis; Natera; Guardant; Genentech; Foundation Medicine; Eli Lily; Eli Lilly; BMS; Array

A,C,O Speaker

Park Morag McGill University, Montréal, Canada No Relationships Program Committee

Parolia Abhijit University of Michigan No Relationships Speaker

Paulovich Amanda Fred Hutchinson Cancer Research Center Precision Assays, LLC O Speaker

Pearce Celeste Leigh University of Michigan School of Public Health No Relationships Speaker

Pe’er Dana Memorial Sloan Kettering Cancer Center No Relationships Speaker

Percac-Lima Sanja Massachusetts General Hospital Merck Foundation C,G,H Speaker

Perl Alexander University of Pennsylvania NewLink Genetics; Leukemia & Lymphoma Society; Forma Therapeutics; Daiichi Sankyo; Bayer; Astellas; Arog; Actinium Pharmaceuticals; Abbvie

C,G,H,O Speaker

Last Name First Name Company Relationships Type Role

21

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Peters Solange Centre Hospitalier Universitaire Vaudois Debiopharm, Eli Lilly, Roche, Illumina, Janssen, MSD, Merck Serono; Daiichi Sankyo, Novartis, Pharma Mar, Pfizer, Regeneron, Seattle Genetiocs; Boehringer Ingelheim; BMS, Takeda, Vaccibody; Biovent; Biocartis; Bayer; Astra Zeneca; Amgen; Abbvie

A,H Speaker

Petersen Gloria Mayo Clinic No Relationships Program Committee

Peyton Shelly University of Massachusetts - Amherst No Relationships Speaker

Pfister Stefan Hopp Children’s Cancer Center Heidelberg (KiTZ) IMI-2 funding involving several EFPIA companies

G Speaker

Philippar Ulrike Janssen R&D Janssen R&D E Speaker

Phillips Andrew C4 Therapeutics C4 Therapeutics E Speaker

Piaggio Eliane INSERM U872 (Cordeliers Research Ctr.) Hifibio; Egle Therapeutics; Crown Bioscience C,S Speaker

Piantadosi Steven Brigham and Women’s Hospital No Relationships Program Committee

Pierga Jean-Yves Institute Curie Roche Genentech; Pfizer; Novartis; Daiichi Sankyo; Astra Zeneca

G,A,H Speaker

Pike Kurt AstraZeneca GlaxoSmithKline; AstraZeneca E,S Speaker

Plevritis Sylvia Stanford University No Relationships Speaker

Politi Katerina Yale Cancer Center Roche/Genentech; MSKCC/MolecularMD; AstraZeneca; Dynamo Therapeutics; Maverick Therapeutics

C,G,O Program Committee, Speaker

Pollak Michael McGill University and Segal Cancer Centre, Canada No Relationships Program Committee

Pouwels Jeroen University of Helsinki Galapagos; Biomedicum Genomics; Bayer; Astrazeneca

C,SB Speaker

Prabhu Varun Vijay Oncoceutics, Inc. Oncoceutics, Inc. E Speaker

Prasad Vinay University of California several universities, medical centers, nonprofit groups, and professional societies; Patreon; Medscape; Johns Hopkins University Press; Arnold Ventures

G,H,O Speaker

Pugh Trevor University of Toronto Merck, Chrysalis Biomedical C,H Program Committee

Puig-Saus Cristina David Geffen School of Medicine at UCLA ArsenalBio O Speaker

Last Name First Name Company Relationships Type Role

22

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Pylayeva-Gupta Yuliya UNC Lineberger Comp. Cancer Center NCI; Department of Defense G Speaker

Quijano-Rubio Alfredo University of Washington Neoleukin Therapeutics S Speaker

Raben David University of Colorado Cancer Center and Genentech Genentech; EQRx E Speaker

Raca Gordana Children’s Hospital of Los Angeles No Relationships Program Committee, Speaker

Ramalingam Suresh Emory University Winship Cancer Institute Amgen, Abbvie, BMS, Genentech, Merck, AstraZeneca, Takeda, Tesaro, Advaxis

C,G Program Committee

Ramirez Amelie UT Health Science Center at San Antonio No Relationships Speaker

Rassool Feyruz University of Maryland School of Medicine No Relationships Speaker

Rathmell Jeffrey Vanderbilt Univ. Medical Ctr. Tempest; Sitryx; Pfizer; Merck; Kadmon; Incyte; Caribou Biosciences; Calithera

A,G,H,S Speaker

Rebbeck Timothy Harvard School of Public Health No Relationships Program Committee

Rebecca Vito Univ. of Pennsylvania No Relationships Speaker

Redman Mary Fred Hutchinson Cancer Research Ctr. No Relationships Speaker

Reis-Filho Jorge Mem. Sloan Kettering Cancer Ctr. Volition RX; Ventana Medical Systems; Roche Tissue Diagnostics; REPARE Therapeutics; Paige.AI; Novartis; InVicro; Goldman Sachs; Genentech

A,C Speaker

Ren Bing UCSD School of Medicine Decipher Biosciences; Aviva Systems Biology; Arima Genomics, Inc.

A,S Speaker

Rescigno Maria Humanitas University Postbiotica; MillBo; Kraft-Heinz; Intercept pharmaceuticals; Gelesis; Casillo group

A,G,S Speaker

Reticker-Flynn Nathan Stanford University No Relationships Speaker

Retzlaff Jon American Association for Cancer Research No Relationships Program Committee

Riaz Nadeem Memorial Sloan Kettering Cancer Center REPARE Therapuetics; Pfizer; BMS C,G Speaker

Ribas Antoni UCLA Medical Center Amgen, Chugai, Genentech, Merck, Novartis, Sanofi, Advaxis, Arcus, Highlight, Compugen, CytomX, Five Prime, RAPT, ImaginAb, Isoplexis, Kite-Gilead, Merus, Rgenix, Lutris, PACT Pharma, Tango Therapeutics

A,C,H, S,O

Program Committee, Speaker

Rigamonti Nicolo Molecular Partners AG Molecular Partners AG E Speaker

Last Name First Name Company Relationships Type Role

23

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Rimm David Yale University School of Medicine Amgen; AZ; Biocept; BMS; Cell Signaling Technology; Cepheid; Daiichi Sankyo; GSK; Konica/Minolta; Merck; Nanostring; Ventana; Ultivue; Navigate BioPharma; NextCure; Lilly; Akoya/Perkin Elmer; PixelGear; Rarecyte

A,C,G, H,S,O

Program Committee, Speaker

Rivero-Hinojosa Samuel Children’s National Hospital No Relationships Speaker

Rodon Ahnert Jordi UT MD Anderson Cancer Center Spectrum Pharmaceuticals Inc; BioAtla; Pfizer; GenMab; Tocagen; CytomX Symphogen; Roche Pharmaceuticals; Pfizer; Orion Pharmaceuticals; IONCTURA SA; Kelun Pharmaceutical/Klus Pharma; Peptomyc; Ellipses Pharma; Eli Lilly, Bayer

A,G,O Speaker

Rosenberg Steven National Cancer Institute No Relationships Speaker

Rubin Joshua Washington University School of Medicine No Relationships Program Committee, Speaker

Rubinstein Wendy U.S. Food and Drug Administration AstraZeneca E Speaker

Rudolph Joachim Genentech, Inc. Genentech, Inc. E,S Speaker

Sadelain Michel Memorial Sloan Kettering Cancer Ctr. No Relationships Program Committee

Sahin Ugur BioNTech AG BioNTech AG E,O Speaker

Sahni Nidhi UT MD Anderson Cancer Center No Relationships Speaker

Sarkaria Jann Mayo Clinic College of Medicine Novartis. ; Basilea. ; Genentech. ; Sanofi. ; Beigene. ; Lilly. ; Glaxo-Smith-Kline. ; Peloton. ; Glionova. ; Bristol-Myers Squibb Pharmaceuticals. ; Cavion. ; Curtana. ; Forma. ; Abbvie. ; Actuate. ; Boehringer Ingelheim. ; Bayer. ; Celgene. ; Cible. ; Wayshine

G Speaker

Sasso Maria Stella University of Chicago No Relationships Speaker

Satchi-Fainaro Ronit Tel Aviv University Teva Pharmaceutical Industries Ltd.; Merck A,G Speaker

Satpathy Shankha Broad Institute of MIT and Harvard No Relationships Speaker

Sayem Mohammad Keio University No Relationships Speaker

Last Name First Name Company Relationships Type Role

24

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Schalper Kurt Yale University Clinica Alemana Santiago; Celgene; Moderna Therapeutics; Shattuck Labs; Pierre-Fabre, AstraZeneca; Dyanamo Therapeutics; EMD Serono; Takeda; Torque Therapeutics; Agenus; Genoptix/Navigate (Novartis); Vasculox/Tioma; Tesaro; Onkaido Therapeutics; Takeda Pharmaceuticals; Surface Oncology; Pierre-Fabre Research Institute; Merck; Bristol-Myers Squibb; Eli Lilly; Fluidigm

C,G,SB Speaker

Schedin Pepper Oregon Health & Science University No Relationships Speaker

Scheet Paul UT MD Anderson Cancer Center No Relationships Speaker

Schilder Russell Thomas Jefferson University Kimmel Cancer Center Incyte, Immunogen, Celsion, Flatiron A,C Program Committee

Schimmer Aaron Princess Margaret Cancer Centre Theravance; Takeda Pharmaceuticals; Otsuka; Novartis; Myovant; Medivir AB; Jazz Pharmaceuticals; AbbVie

G,H,S Speaker

Schmitt Clemens Charité - Universitätsmedizin Berlin No Relationships Speaker

Schwartz Lawrence Columbia University Medical Center No Relationships Speaker

Scott James AstraZeneca AstraZeneca E Speaker

Scroggins Mary In My Sister’s Care and Pinkie Hugs, LLC No Relationships Program Committee

Sequist Lecia Massachusetts General Hospital Novartis; LOXO; Janssen; Genentech; Boehringer Ingelheim; Blueprint Medicines; AstraZeneca

C,G,H Speaker

Shahrokh Esfahani Mohammad Stanford University No Relationships Speaker

Shalek Alex MIT Honeycomb Biotechnologies, Merck, Cellarity, Repertoire, Orche, Dalia

C,A,S Speaker

Sharma Padmanee UT MD Anderson Cancer Center Oncolytics, Jounce, BioAtla, Forty-Seven, Polaris, Marker, Codiak, ImaginAB, Hummingbird, Dragonfly, Lytix, Lava Therapeutics, and Achelois; Jounce; Constellation, Oncolytics, Apricity Health, Hummingbird, Dragonfly, Lytix, Lava Therapeutics, Achelois,

C,S,O Speaker

Last Name First Name Company Relationships Type Role

25

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Sharp Phillip Koch Institute for Integrative Cancer Research at MIT Vir Biotechnology; Syros Pharmaceuticals; Skyhawk Therapeutics; Dewpoint Therapeutics; Alnylam Pharmaceuticals

A,C,S Speaker

Sharpless Norman National Cancer Institute No Relationships Speaker

Shen Hui Van Andel Research Institute AnchorDx S Program Committee, Speaker

Sherman Mara Oregon Health & Science University No Relationships Speaker

Shi Xingyi Boston University School of Medicine No Relationships Speaker

Shields Anthony Barbara Ann Karmanos Cancer Institute Caris Life Sciences, Inovio, ImaginAb, Xencor, Incyte, Daiichi, MSK, Plexxikon, H3 Biomedicine, Eisai, LSK BioPartners, Inc, Halozyme, Inc, Lexicon, Boehringer Ingelheim, Exelexis, Bayer, Taiho, Torque, AstraZeneca, Astellas

G Program Committee

Shokat Kevan UCSF Wellspring Biosciences/Araxes; Revolution Medicines (https://revmed.com); QuLab, Inc.; Merck, Inc.; Kura Oncology; Kumquat Biosciences; Janssen Pharmaceuticals; Genentech/Roche; Dice Molecules; Denali Therapeutics; Erasca; Venthera; Mitokin

A,C,S Speaker

Shyr Yu Vanderbilt-Ingram Cancer Center Roche, Janssen, Pfizer, Aduro Biotech, Novartis C Program Committee

Singh Anand National Cancer Institute, NIH No Relationships Speaker

Singh Bhuminder Vanderbilt University Medical Center No Relationships Speaker

Singh Harpreet U.S. Food and Drug Administration No Relationships Speaker

Smith Catherine UCSF Revolution Medicines; Fuji Film; Daiichi Sanyko; Astellas Pharma; Amgen; AbbVie

A,G,H Speaker

Smith Victoria Amphivena Therapeutics Inc Amphivena Therapeutics Inc E Speaker

Socinski Mark Florida Hospital Cancer Institute Genentech, Lilly, Spectrum, Novartis, AZ, BMS, Guardant, Celgene

A,G,H,SB Program Committee

Solanki Hitendra H. Lee Moffitt Cancer Center No Relationships Speaker

Song Minkyo National Cancer Institute No Relationships Speaker

Soria Jean-Charles MedImmune AZ, Gritstone E,S Program Committee

Last Name First Name Company Relationships Type Role

26

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Sosa Maria Icahn School of Medicine at Mount Sinai Loxo; Exelixis; GlaxoSmithKline, Novo Nordisk, AstraZeneca, Eli Lilly

A,G,O Speaker

Speicher Michael Medical University of Graz Servier; Janssen Oncology G,H Speaker

Staudt Louis NCI-CCR No Relationships Program Committee

Steeg Patricia National Cancer Institute AstraZeneca/MedImmune G Speaker

Steele Maria Perlmutter Cancer Center at NYU Langone Health No Relationships Speaker

Steele Nina UM No Relationships Speaker

Stellas Dimitris National Cancer Institute at Frederick No Relationships Speaker

Stevens Rick Argonne National Laboratory No Relationships Speaker

Stewart Sheila Washington University Aclaris G Program Committee, Speaker

Stiff Andrew Ohio State University College of Medicine No Relationships Speaker

Stover Elizabeth Dana-Farber Cancer Institute No Relationships Speaker

Stroh Christopher Translational Innovation Platform, Oncology, Merck KGaA

Translational Innovation Platform, Oncology, Merck KGaA

E Speaker

Stromnes Ingunn University of Minnesota Luminary Therapeutics A Speaker

Stupp Roger Northwestern University Novartis, Bayer Pharma, Northwest Bio, ZaiLab C,SB,O Program Committee

Subklewe Marion The Gene Center Munich No Relationships Speaker

Sun Fangxian Sanofi US Sanofi US E Speaker

Sun Weijing University of Kansas Medical Center Merck, Agios, Taho A,C,G,SB Program Committee, Speaker

Sutcliffe Julie University of California, Davis (UC Davis) Luminance BioSciences, Inc; Cellsight Technologies, Inc.

A,C,G,S Speaker

Swanton Charles The Francis Crick Institute and UCL Cancer Institute Pfizer, Novartis, GlaxoSmithKline, MSD, BMS, Celgene, AstraZeneca, Illumina, Sarah Canon Research Institute, Genentech, Roche-Ventana, GRAIL, Medicxi. Advisor for Dynamo Therapeutics, BI, Apogen Biotechnologies, Epic Bioscience, GRAIL, Achilles Therapeutics

A,C,G, H,S

Program Committee

Swartz Melody University of Chicago No Relationships Speaker

Last Name First Name Company Relationships Type Role

27

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Sweet-Cordero Alejandro UCSF No Relationships Program Committee

Szalai Bence Semmelweis University No Relationships Speaker

Takahashi Hideyuki Gunma University No Relationships Speaker

Tao Ting Dana-Farber Cancer Institute No Relationships Speaker

Taube Janis Johns Hopkins University School of Medicine Merck & Co; Compugen; Bristol-Myers Squibb; AstraZeneca; Akoya Biosciences

A,C,G,O Speaker

Taunton Jack UCSF Principia; Pfizer; Kezar Life Sciences; Global Blood Therapeutics; Genentech; Cedilla Therapeutics

C,G,H,S Speaker

Teng Michele QIMR Berghofer Medical Research Institute BMS, MSD, Arcus, Novartis, Roche, BI, Tizona C,SB Speaker

Terry Mary Beth Columbia University School of Public Health No Relationships Program Committee

Theodorescu Dan Cedars-Sinai Medical Center Urogen Pharma, Machavert Pharamaceuticals, Merck Sharp & Dohme Corp, Aurora Oncology, Lahjavida, Synlogic

C,S Program Committee

Theoret Marc U.S. Food and Drug Administration No Relationships Speaker

Thiery Jean-Paul Institute Gustave Roussy Biosyngen PTE LTD Singapre; Biocheetah PTE LTD Singapore; Aimaginostics PTE LTD Singapore

A,C Speaker

Timpson Paul Garvan Institute of Medical Research INxmed; Amplia C Speaker

Ting Angela The Cleveland Clinic No Relationships Speaker

Tomasetti Cristian Johns Hopkins University School of Medicine Thrive O Speaker

Trent Jeffrey TGen (The Translational Genomics Research Institute) No Relationships Speaker

Tripathi Brajendra National Cancer Institute No Relationships Speaker

Tschurtschenthaler Markus Technical University of Munich No Relationships Speaker

Tseng Yuen-Yi Broad Institute of MIT and Harvard No Relationships Speaker

Tucker-Kellogg Lisa Duke-NUS Medical School No Relationships Speaker

Turcotte Amelie Université Laval No Relationships Speaker

Tyner Jeffrey OHSU Knight Cancer Institute Syros; Seattle Genetics; Petra; Janssen; Incyte; Gilead; Genentech; Constellation Pharmaceuticals; AstraZeneca; Aptose Biosciences

G Speaker

Last Name First Name Company Relationships Type Role

28

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Ulrich Cornelia Huntsman Cancer Institute No Relationships Program Committee

Umar Asad NCI-DCP No Relationships Speaker

Ushijima Toshikazu National Cancer Center Research Institute No Relationships Speaker

Valeri Nicola Royal Marsden Hospital Institute of Cancer Res. Pfizer; Merck Serono; Eli Lilly; Bayer SB Speaker

Valk Peter Erasmus Medical Center No Relationships Speaker

van Riet Job Erasmus MC No Relationships Speaker

Van Tine Brian Washington University Lilly, Epizyme, CytRx, Janssen, Caris, Pfizer, Merck, Immune Design, Daiichi Sankyo, Adaptimmune, Plexxicon, Tracon, Bayer

A,C,G,SB Program Committee

Van Valen David California Institute of Technology No Relationships Speaker

Varner Judith UCSD Moores Cancer Center VLP Therapeutics; Second Genome; MiNA Therapeutics; Gossamer; Argent Therapeutics; AlphaBeta Therapeutics

A,C,G, S,O

Speaker

Vasan Neil Memorial Sloan Kettering Cancer Center Volastra Therapeutics; Petra Pharma; Novartis A,C,H Speaker

Vasbinder Melissa Ribon Theraspeutics Inc Ribon Therapeutics E,S Program Committee

Vickovic Sanja Broad Institute of MIT and Harvard No Relationships Speaker

Vilar-Sanchez Eduardo UT MD Anderson Cancer Center TFS KOL; Janssen Research and Development A,C,H Speaker

Viswanadhapalli Suryavathi UT Health San Antonio No Relationships Speaker

Wages Nolan University of Virginia No Relationships Speaker

Walsh Bill Healthy Building Network No Relationships Speaker

Wan Liling University of Pennsylvania No Relationships Speaker

Wang C.K. COTA Healthcare No Relationships Speaker

Wang Jean Princess Margaret Cancer Centre Trillium Therapeutics Inc. (TTI) O Speaker

Wang Ting Washington University School of Medicine No Relationships Speaker

Wang Xiaojing Genentech, Inc. Genentech, EQRx E Speaker

Ward Mary National Cancer Institute No Relationships Speaker

Ward Richard AstraZeneca AstraZeneca Pharmaceuticals E Speaker

Last Name First Name Company Relationships Type Role

29

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Wargo Jennifer UT MD Anderson Cancer Center Roche/Genentech, Novartis, AstraZeneca, GSK, BMS, Merck, Microbiome DX, Biothera Pharmaceuticals, Imedex, Dava Oncology, Omniprex, Illumina, Gilead, MedImmune, Patent Application, PeerView, Physician Education Resource, Exelixis

A,C,E,G, SB,O

Program Committee, Speaker

Watowich Stephanie UT MD Anderson Cancer Center Ridgeline Therapeutics E,O Program Committee, Speaker

Watson Philip Memorial Sloan Kettering Cancer Center No Relationships Speaker

Weeraratna Ashani The Sidney Kimmel Cancer Center at Johns Hopkins School of Medicine

Phoremost Technologies A Speaker

Wei Jia The Comprehensive Cancer Center of Drum-Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University

No Relationships Speaker

Wei Jun National Cancer Inst. No Relationships Speaker

Weichselbaum Ralph University of Chicago Cancer Research Center NKMax America Inc; Nano proteagen; Merck Serono, S.A.; Magi Therapeutics; ImmunoVir LLC; Genus; Coordination Pharmaceuticals Inc; Boost Therapeutics Inc.; Astrazeneca; Aettis Inc.

C,S,O Speaker

Weiner David The Wistar Institute Sanofi; Inovio; Geneos; GeneOne; BBI; AstraZeneca

A,C,G,S Speaker

Wenzel Alexander UC San Diego No Relationships Speaker

Westcott Peter MIT Koch Institute for Integrated Cancer Res. No Relationships Speaker

Wherry Edward University of Pennsylvania Merck; Roche; Pieris; Elstar; Surface Oncology; Eli Lilly; Celgene; MedImmune; Bristol-Myers Squibb; Arsenal Biosciences; Arcus; DynaVax, KyMab

C,G,H, S,O

Speaker

Whitley Owen University of Toronto No Relationships Speaker

Winn Robert Virginia Commonwealth University, Massey Cancer Center

No Relationships Speaker

Last Name First Name Company Relationships Type Role

30

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Wistuba Ignacio UT MD Anderson Cancer Center Genentech/Roche, Astra Zeneca/Medimmune, MSD, Pfizer, Bristol-Myers Squibb, Bayer, HTG Molecular, Asuragen, Merck, GlaxoSmithKline, Guardant Health, Oncoplex, HTG Molecular, DepArray, Merck, Adaptive, Adaptimmune, EMD Serono, Takeda, Amgen, Karus, Johnson & Johnson, Bayer, Iovance, 4D, Novartis, Akoya

A,G,SB Program Committee

Wolchok Jedd Memorial Sloan Kettering Cancer Center Adaptive Biotech; Advaxis; Amgen; Apricity; Array BioPharma; Ascentage Pharma; Bayer; Beigene; Bristol Myers Squibb; Chugai; Elucida; Eli Lilly; F Star; Genentech; Imvaq; Kyowa Hakko Kirin; Merck; Neon Therapuetics; Northern Biologics; Ono; Polaris Pharma; Polynoma; Psioxus; Recepta; Takara Bio; Trieza; Sellas Life Sciences; Serametrix; Surface Oncology; Syndax,; Syntalogic; MedImmune; Potenza; Tizona; Linnaeus

C,G,S Speaker

Wong Jason National Cancer Institute No Relationships Speaker

Wood Laura Johns Hopkins University School of Medicine No Relationships Speaker

Wozniak Agnieszka KU Leuven No Relationships Speaker

Wu Guojun Barbara Ann Karmanos Cancer Institute No Relationships Speaker

Wu Ronald University of Toronto No Relationships Speaker

Yala Adam Massachusetts Institute of Technology No Relationships Speaker

Yamauchi Takayoshi Roswell Park Comprehensive Cancer Center No Relationships Speaker

Yang Jing University of California, San Diego No Relationships Program Committee, Speaker

Yap Timothy UT MD Anderson Cancer Center AZ, Bayer, Pfizer, Tesaro, Jounce, Eli Lilly, Seattle Genetics, Kyowa, Constellation, Aduro, Almac, AstraZeneca, Atrin, Bayer, Bristol-Myers Squibb, Calithera, Clovis, Cybrexa, EMD Serono, Ignyta, Jansen, Merck, Pfizer, Roche, Vertex Pharmaceuticals

SB,C,G Speaker

Ye Jiangbin Stanford University School of Medicine No Relationships Speaker

Yip Stephen University of British Columbia Bayer, Pfizer, Roche A,H Program Committee

Last Name First Name Company Relationships Type Role

31

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Yoon Hyung-Suk Vanderbilt University Medical Center No Relationships Speaker

Yu David Emory University School of Medicine No Relationships Speaker

Yu Jennifer The Cleveland Clinic No Relationships Program Committee, Speaker

Yu Xin Rutgers Cancer Institute of New Jersey No Relationships Speaker

Yuan Guo-Cheng Harvard T.H. Chan School of Public Health No Relationships Speaker

Yuan Jian-Min University of Pittsburgh No Relationships Speaker

Yue Feng Northwestern University No Relationships Speaker

Zacharakis Nikolaos NIH-NCI (National Cancer Institute) No Relationships Speaker

Zhang Bing Baylor College of Medicine TNIK Therapeutics; Bristol-Myers Squibb C,G Speaker

Zhang Xuehong Harvard Medical School No Relationships Speaker

Zhang Yin Brigham and Women’s Hospital and Harvard Medical School

No Relationships Speaker

Zhou Ting Yale School of Medicine No Relationships Speaker

Zitvogel Laurence Institute Gustave Roussy Transgene; Lytix Biopharma; Kaleido; Innvovate Pharma; GSK; everImmune; EpiVax

A,G,H,S Speaker

Zou Weiping University of Michigan Oncopia; Hengenix Biotech; Hengenix; CStone A Speaker

Zuo Qianying University of Illinois at Urbana-Champaign No Relationships Speaker